Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and marfan syndrome : A statement for healthcare professionals from the councils on clinical cardiology, cardiovascular disease in the young, and basic science, american heart association
Barry J. Maron(Lahey Hospital and Medical Center), Christine E. Seidman(Harvard University), Harry C. Dietz(Johns Hopkins University), Arthur J. Moss(University of Rochester), James H. Moller(University of Minnesota), G. Michael Vincent(University of Pavia)
PubMed
October 6, 1998
Cited by 125
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
|Circulation|1995|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Sudden Deaths in Young Competitive Athletes
|Circulation|2009|2k